{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T03:29:18Z","timestamp":1773631758173,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003443","name":"Ministry of Education and Science of the Russian Federation","doi-asserted-by":"publisher","award":["1022040700963\\u20138"],"award-info":[{"award-number":["1022040700963\\u20138"]}],"id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.intimp.2024.112121","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T08:56:52Z","timestamp":1713776212000},"page":"112121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The immunostimulatory roles of gold nanoparticles in immunization and vaccination against Brucella abortus antigens"],"prefix":"10.1016","volume":"133","author":[{"given":"Sergey A.","family":"Staroverov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman D.","family":"Vyrshchikov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir A.","family":"Bogatyrev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2440-6761","authenticated-orcid":false,"given":"Lev A.","family":"Dykman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.112121_b0005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11259-015-9645-2","article-title":"Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization","volume":"39","author":"Abkar","year":"2015","journal-title":"Vet. Res. Commun."},{"key":"10.1016\/j.intimp.2024.112121_b0010","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.imlet.2019.01.010","article-title":"A comparison between adjuvant and delivering functions of calcium phosphate, aluminum hydroxide and chitosan nanoparticles, using a model protein of Brucella melitensis Omp 31","volume":"207","author":"Abkar","year":"2019","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.intimp.2024.112121_b0015","doi-asserted-by":"crossref","first-page":"7625","DOI":"10.1007\/s00253-015-6787-7","article-title":"Prediction of T cell epitopes of Brucella abortus and evaluation of their protective role in mice","volume":"99","author":"Afley","year":"2015","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.intimp.2024.112121_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2020.110021","article-title":"Immunological effects of two new nanovaccines against Brucella based on OPS and LPS antigens conjugated with PLGA nanoparticles","volume":"139","author":"Afshari","year":"2020","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.intimp.2024.112121_b0025","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1586\/eri.11.55","article-title":"Implications of laboratory diagnosis on brucellosis therapy","volume":"9","author":"Al Dahouk","year":"2011","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"10.1016\/j.intimp.2024.112121_b0030","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/743509","article-title":"A history of the development of Brucella vaccines","volume":"2013","author":"Avila-Calderon","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.intimp.2024.112121_b0035","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1006\/abbi.2000.1907","article-title":"The role of plasma membrane in bioreduction of two tetrazolium salts, MTT, and CTC","volume":"380","author":"Bernas","year":"2000","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.intimp.2024.112121_b0040","first-page":"1946","volume":"10","author":"Bezbaruah","year":"2022","journal-title":"Nanoparticle-Based Delivery Systems for Vaccines. Vaccines"},{"key":"10.1016\/j.intimp.2024.112121_b0045","doi-asserted-by":"crossref","first-page":"e02370","DOI":"10.1016\/j.heliyon.2019.e02370","article-title":"Sustained antigen release polyanhydride-based vaccine platform for immunization against bovine brucellosis","volume":"5","author":"Boggiatto","year":"2019","journal-title":"Heliyon"},{"key":"10.1016\/j.intimp.2024.112121_b0050","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jconrel.2012.07.030","article-title":"Conjunctival vaccination against Brucella ovis in mice with mannosylated nanoparticles","volume":"162","author":"Da Costa","year":"2012","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.intimp.2024.112121_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2022.101668","article-title":"Optimized protocol to isolate primary mouse peritoneal macrophage metabolites","volume":"3","author":"De Jesus","year":"2022","journal-title":"STAR Protoc."},{"key":"10.1016\/j.intimp.2024.112121_b0060","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/14760584.2020.1758070","article-title":"Gold nanoparticles for preparation of antibodies and vaccines against infectious diseases","volume":"19","author":"Dykman","year":"2020","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.intimp.2024.112121_b0065","first-page":"350","article-title":"Colloidal gold in solid-phase assays","volume":"62","author":"Dykman","year":"1997","journal-title":"A Review. Biochemistry (moscow)"},{"key":"10.1016\/j.intimp.2024.112121_b0070","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1039\/C6SC03631G","article-title":"Immunological properties of gold nanoparticles","volume":"8","author":"Dykman","year":"2017","journal-title":"Chem. Sci."},{"key":"10.1016\/j.intimp.2024.112121_b0075","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.intimp.2017.11.008","article-title":"Gold nanoparticles as an adjuvant: Influence of size, shape, and technique of combination with CpG on antibody production","volume":"54","author":"Dykman","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.112121_b0080","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1016\/j.vaccine.2006.01.038","article-title":"Experiments on a sub-unit vaccine encapsulated in microparticles and its efficacy against Brucella melitensis in mice","volume":"24","author":"Estevan","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2024.112121_b0085","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/wnan.1403","article-title":"Particulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogens","volume":"9","author":"Fan","year":"2017","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.intimp.2024.112121_b0090","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/physci241020a0","article-title":"Controlled nucleation for the regulation of the particle size in monodisperse gold suspensions","volume":"241","author":"Frens","year":"1973","journal-title":"Nat. Phys. Sci."},{"key":"10.1016\/j.intimp.2024.112121_b0095","doi-asserted-by":"crossref","first-page":"2280377","DOI":"10.1080\/21505594.2023.2280377","article-title":"One-step preparation of a self-assembled bioconjugate nanovaccine against Brucella","volume":"14","author":"Huang","year":"2023","journal-title":"Virulence"},{"key":"10.1016\/j.intimp.2024.112121_b0100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cimid.2019.03.015","article-title":"Immunogenic and protective antigens of Brucella as vaccine candidates","volume":"65","author":"Jezi","year":"2019","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.intimp.2024.112121_b0105","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1039\/C0CS00018C","article-title":"Biodistribution and toxicity of engineered gold nanoparticles: A review of in vitro and in vivo studies","volume":"40","author":"Khlebtsov","year":"2011","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.intimp.2024.112121_b0110","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1128\/CMR.16.1.65-78.2003","article-title":"Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans","volume":"16","author":"Ko","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.intimp.2024.112121_b0115","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2024.112121_b0120","doi-asserted-by":"crossref","first-page":"4248","DOI":"10.1080\/21691401.2019.1687490","article-title":"Preparation of a nanovaccine against Brucella melitensis M16 based on PLGA nanoparticles and oligopolysaccharide antigen","volume":"47","author":"Maleki","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.intimp.2024.112121_b0125","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3389\/fimmu.2017.00239","article-title":"Role of metallic nanoparticles in vaccinology: implications for infectious disease vaccine development","volume":"8","author":"Marques Neto","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112121_b0130","volume":"eBioMedicine 99","author":"Miauton","year":"2024","journal-title":"Safety and Immunogenicity of a Synthetic Nanoparticle-Based, T Cell Priming Peptide Vaccine against Dengue in Healthy Adults in Switzerland: a Double-Blind, Randomized, Vehicle-Controlled, Phase 1 Study."},{"key":"10.1016\/j.intimp.2024.112121_b0135","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.intimp.2024.112121_b0140","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1016\/S0264-410X(01)00177-3","article-title":"A Brucella ovis antigenic complex bearing poly-epsilon-caprolactone microparticles confer protection against experimental brucellosis in mice","volume":"19","author":"Murillo","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2024.112121_b0145","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1073\/pnas.022649799","article-title":"Human macrophage activation programs induced by bacterial pathogens","volume":"99","author":"Nau","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.intimp.2024.112121_b0150","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1056\/NEJMra050570","article-title":"Brucellosis","volume":"352","author":"Pappas","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2024.112121_b0155","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.3389\/fimmu.2018.02224","article-title":"Nanoparticle vaccines against infectious diseases","volume":"9","author":"Pati","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112121_b0160","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.2147\/IJN.S249942","article-title":"Nanoparticle-based vaccines for brucellosis: calcium phosphate nanoparticles-adsorbed antigens induce cross protective response in mice","volume":"15","author":"Sadeghi","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.intimp.2024.112121_b0165","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/vms3.1221","article-title":"Current status of nano-vaccinology in veterinary medicine science","volume":"9","author":"Sadr","year":"2023","journal-title":"Vet. Med. Sci."},{"key":"10.1016\/j.intimp.2024.112121_b0170","first-page":"e00934","volume":"mSphere 7","author":"Sanchez-Villamil","year":"2022","journal-title":"Optimization of Multivalent Gold Nanoparticle Vaccines Eliciting Humoral and Cellular Immunity in an in Vivo Model of Enterohemorrhagic Escherichia Coli O157:H7 Colonization."},{"key":"10.1016\/j.intimp.2024.112121_b0175","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3390\/vaccines10040505","article-title":"Efficacy and immune response elicited by gold nanoparticle- based nanovaccines against infectious diseases","volume":"10","author":"Sengupta","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.intimp.2024.112121_b0180","doi-asserted-by":"crossref","unstructured":"Shah, K., Maghsoudlou, P., 2016. Enzyme\u2013linked immunosorbent assay (ELISA): the basics. Br J. Hosp. Med. 77, C98-C101. 10.12968\/hmed.2016.77.7.C98.","DOI":"10.12968\/hmed.2016.77.7.C98"},{"key":"10.1016\/j.intimp.2024.112121_b0185","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1039\/C7MD00158D","article-title":"Applications and perspectives of nanomaterials in novel vaccine development","volume":"9","author":"Shen","year":"2018","journal-title":"MedChemComm"},{"key":"10.1016\/j.intimp.2024.112121_b0190","doi-asserted-by":"crossref","first-page":"10644","DOI":"10.1021\/la0513712","article-title":"Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview","volume":"21","author":"Shukla","year":"2005","journal-title":"Langmuir"},{"key":"10.1016\/j.intimp.2024.112121_b0195","first-page":"e58022","article-title":"The use of mouse splenocytes to assess pathogen-associated molecular pattern influence on clock gene expression","volume":"137","author":"Silver","year":"2018","journal-title":"J. vis. Exp."},{"key":"10.1016\/j.intimp.2024.112121_b0200","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1016\/j.vaccine.2015.04.030","article-title":"Recombinant L7\/L12 protein entrapping PLGA (poly lactide-co-glycolide) micro particles protect BALB\/c mice against the virulent B. abortus 544 infection","volume":"33","author":"Singh","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2024.112121_b0205","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.molimm.2015.09.011","article-title":"PLGA (85:15) nanoparticle based delivery of rL7\/L12 ribosomal protein in mice protects against Brucella abortus 544 infection: A promising alternate to traditional adjuvants","volume":"68","author":"Singh","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.intimp.2024.112121_b0210","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/j.vaccine.2015.03.063","article-title":"M2e-immobilized gold nanoparticles as influenza A vaccine: Role of soluble M2e and longevity of protection","volume":"33","author":"Tao","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2024.112121_b0215","first-page":"e01227","volume":"mBio 12","author":"Tapia","year":"2020","journal-title":"Multicomponent Gold-Linked Glycoconjugate Vaccine Elicits Antigen-Specific Humoral and Mixed TH1-TH17 Immunity, Correlated with Increased Protection against Burkholderia Pseudomallei."},{"key":"10.1016\/j.intimp.2024.112121_b0220","doi-asserted-by":"crossref","first-page":"2305061","DOI":"10.1002\/adfm.202305061","article-title":"Advances of nanotechnology toward vaccine development against animal infectious diseases","volume":"33","author":"Wang","year":"2023","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.intimp.2024.112121_b0225","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2174\/1389201014666131226123016","article-title":"Research progress in live attenuated Brucella vaccine development","volume":"14","author":"Wang","year":"2013","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.intimp.2024.112121_b0230","first-page":"26","article-title":"Detection of Brucella antigens by dot immunoassay using specific antibodies labelled with colloid gold particles","volume":"3","author":"Zagoskina","year":"1999","journal-title":"Mol. Genet. Microbiol. Virol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924006398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924006398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T20:08:59Z","timestamp":1715630939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924006398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":46,"alternative-id":["S1567576924006398"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112121","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The immunostimulatory roles of gold nanoparticles in immunization and vaccination against Brucella abortus antigens","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112121","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112121"}}